Neuropathic Pain: Models and Mechanisms

被引:55
作者
Boyce-Rustay, Janel M. [1 ]
Jarvis, Michael F. [1 ]
机构
[1] Abbott Labs, Neurosci Res, Global Pharmaceut Res & Dev, Abbott Pk, IL 60064 USA
关键词
Neuropathic pain; spinal nerve ligation; chronic constriction injury; diabetic neuropathy; chemotherapy-induced neuropathy; SPARED NERVE INJURY; RAT MODEL; NOCICEPTIVE SENSITIVITY; PERIPHERAL NEUROPATHY; CENTRAL SENSITIZATION; MONONEUROPATHIC RATS; DIABETIC-NEUROPATHY; DYNAMIC COMPONENTS; COLD ALLODYNIA; HYPERALGESIA;
D O I
10.2174/138161209788186272
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Advances in the characterization of pain signaling in recent years indicate that distinct neurophysiological and neurochemical mechanisms contribute to pain arising from injury to the nervous system (neuropathic pain). Tissue injury results in the release of pro-nociceptive mediators that sensitize peripheral nerve terminals (peripheral sensitization), leading to neurochemical and phenotypic alterations of sensory neurons and increased excitability of spinal cord dorsal horn neurons (central sensitization). In addition, the response of the nervous system to pain is not static, but is modulated by descending systems originating in the brain that can modulate pain thresholds. In this review, attention is given to the experimental modeling of neuropathic pain in preclinical studies. Recently, an increased understanding of the neurophysiological plasticity of the nervous system in response to chronic pain has led to the discovery and development of novel pharmacological interventions that may have clinical utility in treating neuropathic pain.
引用
收藏
页码:1711 / 1716
页数:6
相关论文
共 68 条
  • [51] Can we conquer pain?
    Scholz, J
    Woolf, CJ
    [J]. NATURE NEUROSCIENCE, 2002, 5 (Suppl 11) : 1062 - 1067
  • [52] SELTZER Z, 1991, Journal of Basic and Clinical Physiology and Pharmacology, V2, P17
  • [53] Neuropathic pain: Drug targets for current and future interventions
    Smith, PA
    [J]. DRUG NEWS & PERSPECTIVES, 2004, 17 (01) : 5 - 17
  • [54] Role of advanced glycation end products in diabetic neuropathy
    Sugimoto, Kazuhiro
    Yasujima, Minoru
    Yagihashi, Soroku
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (10) : 953 - 961
  • [55] Neuropeptide Y acts at Y1 receptors in the rostral ventral medulla to inhibit neuropathic pain
    Taylor, Bradley K.
    Abhyankar, Sarang S.
    Vo, Ngoc-Tram T.
    Kriedt, Christopher L.
    Churi, Sajay B.
    Urban, Janice H.
    [J]. PAIN, 2007, 131 (1-2) : 83 - 95
  • [56] PERIPHERAL AND CENTRAL MECHANISMS OF CUTANEOUS HYPERALGESIA
    TREEDE, RD
    MEYER, RA
    RAJA, SN
    CAMPBELL, JN
    [J]. PROGRESS IN NEUROBIOLOGY, 1992, 38 (04) : 397 - 421
  • [57] Neuropathic pain and spinal microglia: a big problem from molecules in 'small' glia
    Tsuda, M
    Inoue, K
    Salter, MW
    [J]. TRENDS IN NEUROSCIENCES, 2005, 28 (02) : 101 - 107
  • [58] Molecular mechanisms of neuropathic pain-phenotypic switch and initiation mechanisms
    Ueda, H
    [J]. PHARMACOLOGY & THERAPEUTICS, 2006, 109 (1-2) : 57 - 77
  • [59] Supraspinal contributions to hyperalgesia
    Urban, MO
    Gebhart, GF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (14) : 7687 - 7692
  • [60] Vrinten DH, 2000, J NEUROSCI, V20, P8131